Catalyst Pharmaceutical
CPRX
NASDAQ
IPO2006
about CPRX
Catalyst Pharmaceutical develops innovative therapies for rare and lysosomal storage disorders, addressing significant unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $24.26 | $25.00 | $24.18 | $3.0B | 991.98K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.43 | 15.03 | 20.98 | 44.66% | 35.57% | 0% |